Scarica l'app Stockscreener
40.66
3.88%
1.52
Dopo l'orario di chiusura:
40.90
0.24
+0.59%
Kymera Therapeutics Inc Borsa (KYMR) Ultime notizie
HighTower Advisors LLC Takes $494,000 Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
BMO Capital Initiates Coverage of Kymera Therapeutics (KYMR) with Market Perform Recommendation - MSN
BTIG Initiates Coverage of Kymera Therapeutics (KYMR) with Buy Recommendation - MSN
State Street Corp Has $81.79 Million Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Sold by Verition Fund Management LLC - Defense World
(KYMR) Investment Analysis - Stock Traders Daily
Kymera Therapeutics (NASDAQ:KYMR) Now Covered by BTIG Research - MarketBeat
Two Sigma Advisers LP Lowers Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Wellington Management Group LLP Has $218.59 Million Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics (NASDAQ:KYMR) Research Coverage Started at BMO Capital Markets - Defense World
Kymera: Protein Degradation Could Drive Dupixent-Like Value (NASDAQ:KYMR) - Seeking Alpha
BMO Capital Markets Initiates Coverage on Kymera Therapeutics (NASDAQ:KYMR) - MarketBeat
Thrivent Financial for Lutherans Takes $313,000 Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
The Manufacturers Life Insurance Company Has $6.07 Million Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
BMO sets Kymera Therapeutics target at $55, rates Market Perform By Investing.com - Investing.com Canada
Kymera Therapeutics, Inc. (NASDAQ:KYMR) is Redmile Group LLC's 5th Largest Position - MarketBeat
(KYMR) Long Term Investment Analysis - Stock Traders Daily
Bamco Inc. NY Invests $1.18 Million in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Erste Asset Management GmbH Acquires New Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kymera therapeutics director Pamela Esposito sells shares worth $122,500 By Investing.com - Investing.com Nigeria
Kymera therapeutics director Pamela Esposito sells shares worth $122,500 - Investing.com India
12,743 Shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Purchased by HighVista Strategies LLC - MarketBeat
Cinctive Capital Management LP Acquires Shares of 56,801 Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics shares rating upgraded on positive outlook By Investing.com - Investing.com Canada
Kymera Therapeutics (NASDAQ:KYMR) Upgraded by Wells Fargo & Company to Overweight Rating - Defense World
Wells Fargo Upgrades Kymera Therapeutics (KYMR) - MSN
Wells Fargo sees this biotech stock rallying 75% in its bull case - Head Topics
Fred Alger Management LLC Invests $859,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Fmr LLC Boosts Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Intech Investment Management LLC Invests $650,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Intech Investment Management LLC Makes New $650,000 Investment in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Bought by Eventide Asset Management LLC - MarketBeat
14,378 Shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Bought by Natixis Advisors LLC - MarketBeat
Natixis Advisors LLC Purchases Shares of 14,378 Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
Kymera Therapeutics announces proposed underwritten offering - MSN
Kymera Therapeutics to Participate in Upcoming December Investor Conferences - The Manila Times
Kymera Therapeutics to Present at Major Healthcare Investment Conferences in December | KYMR Stock News - StockTitan
Massachusetts Financial Services Co. MA Purchases 47,507 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
(KYMR) Trading Report - Stock Traders Daily
Jennison Associates LLC Purchases 368,394 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Stephens Begins Coverage on Kymera Therapeutics (NASDAQ:KYMR) - Defense World
Kymera Therapeutics (NASDAQ:KYMR) Coverage Initiated by Analysts at Stephens - MarketBeat
US Bancorp DE Sells 651 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
Kymera Therapeutics (NASDAQ:KYMR) Shares Down 6.7%Here's What Happened - MarketBeat
Avoro Capital Advisors LLC Expands Stake in Kymera Therapeutics Inc - GuruFocus.com
Long Term Trading Analysis for (KYMR) - Stock Traders Daily
FMR LLC Bolsters Stake in Kymera Therapeutics Inc - GuruFocus.com
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives $51.21 Average Price Target from Analysts - Defense World
Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $49.00 at Morgan Stanley - Defense World
Analysts Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) Target Price at $51.21 - MarketBeat
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):